Search Contract Opportunities

2021-2022 Pediatric Flu Vaccine   6

ID: 68173 • Type: Award Notice • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:

Description

This is a notice of award.

Show All

Overview

Awardee
Seqirus Usa
Award ID
75D30121D10213
Reported Award
$180,705,000
Agency
Centers for Disease Control and Prevention (CDC) [HHS]
Award Date
Dec. 28, 2020
Posted
Jan. 4, 2021, 10:42 a.m. EST
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Summit, NJ 07901 United States
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
2021-2022 Pediatric Flu Vaccine (68173) was awarded to Seqirus Usa on 1/4/21 by Centers for Disease Control and Prevention.
Primary Contact
Name
William Brannen   Profile
Email
vwl0@cdc.gov
Phone
(770) 488-2084

Documents

Posted documents for Award Notice 68173

Opportunity Assistant

AI Analysis

Opportunity Lifecycle

Procurement notices related to Award Notice 68173

Award Notifications

Agency published notification of awards for Award Notice 68173

Similar Active Opportunities

Open contract opportunities similar to Award Notice 68173

Experts for 2021-2022 Pediatric Flu Vaccine

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > CENTERS FOR DISEASE CONTROL AND PREVENTION > CDC OFFICE OF ACQUISITION SERVICES
FPDS Organization Code
7523-00254
Source Organization Code
100188028
Last Updated
Jan. 12, 2021
Last Updated By
vwl0@cdc.gov
Archive Date
Jan. 12, 2021